期刊
CLINICA CHIMICA ACTA
卷 436, 期 -, 页码 323-328出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.cca.2014.06.022
关键词
Chronic heart failure; Wasting; Hormonal markers; Inflammation; Multimarker strategy
资金
- Portuguese Foundation for Science and Technology (FCT)
- European Union
- QREN
- FEDER
- COMPETE [PEst-C/QUI/U10062/2013]
- [PTDC/DES/114122/2009]
- [FCOMP-01-0124-FEDER-014707]
Cardiac cachexia is a serious complication of chronic heart failure, characterized by significant weight loss and body wasting. Chronic heart failure-related muscle wasting results from a chronic imbalance in the activation of anabolic or catabolic pathways, caused by a series of immunological, metabolic, and neurohormonal processes. In spite of the high morbidity and mortality associated to this condition, there is no universally accepted definition or specific biomarkers for cardiac cachexia, which makes its diagnosis and treatment difficult. Several hormonal, inflammatory and oxidative stress molecules have been proposed as serological markers of prognosis in cardiac cachexia but with doubtful success. As individual biomarkers may have limited sensitivity and specificity, multimarker strategies involving mediators of the biological processes modulated by cardiac cachexia will strongly contribute for the diagnosis and management of the disease, as well as for the establishment of new therapeutic targets. An integrated analysis of the biomarkers proposed so far for cardiac cachexia is made in the present review, highlighting the biological processes to which they are related. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据